Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06576037
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-26
Brief Title:
Phase Ib Study of CBP-1019 in Combination With FOLFOX - Bevacizumab Pembrolizumab or Enzalutamide for Metastatic TRPV6-overexpressing Solid Tumors of Epithelial Origin
Sponsor:
Organization:
None